The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Bourgeois, M.
* Articles by The InterSePT Study Group
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Bourgeois, M.
* Articles by The InterSePT Study Group,
Related Collections
* Depression
* Schizophrenia Spectrum Disorders
* Suicide
Am J Psychiatry 161:1494-1496, August 2004
© 2004 American Psychiatric Association


Brief Report

Awareness of Disorder and Suicide Risk in the Treatment of Schizophrenia: Results of the International Suicide Prevention Trial

Marc Bourgeois, M.D., Joel Swendsen, Ph.D., Frederick Young, Ph.D., Xavier Amador, Ph.D., Stefano Pini, M.D., Giovanni B. Cassano, M.D., Jean-Pierre Lindenmayer, M.D., Chuanchieh Hsu, Ph.D., Larry Alphs, M.D., Ph.D., Herbert Y. Meltzer, M.D., and The InterSePT Study Group

OBJECTIVE: Schizophrenia is characterized by high suicide risk and low awareness of disorder. Although awareness has benefits for medication compliance and clinical outcome, it is unclear how it may relate to suicide risk in this population. METHOD: This multicenter investigation assessed awareness and suicide-related behavior in 980 patients with schizophrenia or schizoaffective disorder. Patients were followed over 2 years and assessed by blinded raters for suicide-related events. RESULTS: Awareness of psychiatric condition at baseline was associated with increased risk of suicide events over the follow-up. This effect was mediated by depression and hopelessness levels. By contrast, changes in awareness associated with treatment decreased the risk of suicide. CONCLUSIONS: Although some patients may become depressed after acknowledging the clinical handicaps of their disorder, treatment-related changes in awareness are generally associated with a positive outcome relative to suicide risk. The complex interactions and mediation effects of these clinical variables require careful monitoring.




This article has been cited by other articles:


Home page
Schizophr BullHome page
S. Bakst, J. Rabinowitz, and E. J. Bromet
Antecedents and Patterns of Suicide Behavior in First-Admission Psychosis
Schizophr Bull, March 9, 2009; (2009) sbp001v1.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
T. M. Lincoln, E. Lullmann, and W. Rief
Correlates and Long-Term Consequences of Poor Insight in Patients With Schizophrenia. A Systematic Review
Schizophr Bull, November 1, 2007; 33(6): 1324 - 1342.
[Abstract] [Full Text] [PDF]


Home page
J Am Acad Psychiatry LawHome page
B. L. Herbel and H. Stelmach
Involuntary Medication Treatment for Competency Restoration of 22 Defendants With Delusional Disorder
J Am Acad Psychiatry Law, March 1, 2007; 35(1): 47 - 59.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org